Abstracts Archive - Page 1512 of 2607 - ACR Meeting Abstracts

Abstract Number: 1871 • 2017 ACR/ARHP Annual Meeting
Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype
Louis Lu¹, Stephanie Moser², Chad M. Brummett² and Daniel J. Clauw³, ¹Anesthesiology & Perioperative Care, UC Irvine, Orange, CA, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: Fibromyalgia is challenging to diagnose given its overlapping symptoms with other chronic pain conditions. The most characteristic feature of FM is widespread pain, operationalized…
Abstract Number: 1872 • 2017 ACR/ARHP Annual Meeting
The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia
Noam Goldwway¹, Haggai Sharon¹, Eti Ben Simon¹, Libat Weizman¹, Ayam Greental¹, Omer Lubin¹, Marc Cavazza², Fred Charles³, Talma Hendler¹ and Jacob N. Ablin⁴, ¹Functional Brain Center, Wohl Institute for Advanced Imaging, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel, ²School of Computing, Teesside University, United Kingdom, Middlesbrough, United Kingdom, ³Department of Creative Technology, Bournemouth University, Bournemouth, United Kingdom, ⁴Rheumatology, Rheumatology Institute, Tel Aviv, Tel Aviv, Israel
Background/Purpose: Fibromyalgia syndrome (FMS) is a condition characterized by widespread pain, sleep disturbance and chronic fatigue, and mood disorder .FMS was suggested to represent a…
Abstract Number: 1873 • 2017 ACR/ARHP Annual Meeting
Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale
Nilamba Jhala¹, Yaseen Kinanah², Sahar Kaouk³, Deb Bork⁴, Sara Davin⁵, Sarah Rispinto⁵, William Wilke⁴ and Carmen E. Gota⁴, ¹Internal Medicine, Cleveland Clinic, Cleveland, OH, ²Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, ³John Carroll University, University Heights, OH, ⁴Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, ⁵Neurologic Institute, Cleveland Clinic, Cleveland, OH
Background/Purpose: Both the fibromyalgia impact questionnaire (FIQ) and the polysymptomatic distress scale (PSD) have been proposed as measures of FM impact and severity. It is…
Abstract Number: 1874 • 2017 ACR/ARHP Annual Meeting
Development of an Ultrasonographic Enthesitis Score for Psoriatic Arthritis Patients
Stephanie Tom^1,2, Yujie Zhong³, Richard J. Cook⁴, Sibel Z. Aydin^5,6, Gurjit S. Kaeley⁷ and Lihi Eder^8,9, ¹Women's College Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom, ⁴Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, ⁵The Ottawa Hospital, Ottawa, ON, Canada, ⁶University of Ottawa, Ottawa, ON, Canada, ⁷University of Florida, Ponte Vedra Beach, FL, ⁸Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ⁹Medicine, University of Toronto, Toronto, ON, Canada
Background/Purpose: Enthesitis affects approximately a third of patients with psoriatic arthritis (PsA) and is often considered the earliest site of inflammation. The accuracy of clinical…
Abstract Number: 1875 • 2017 ACR/ARHP Annual Meeting
Assessment of Structural Damage of the Thumb Base in Patients with Hand Osteoarthritis: Comparing the Newly Developed Omeract Magnetic Resonance Imaging Scoring System with Standard Radiography
S. van Beest¹, F.P.B. Kroon¹, W. Damman¹, R. Liu¹, H.M. Kroon² and M. Kloppenburg³, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Radiology, Leiden University Medical Center, Leiden, Netherlands, ³Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Thumb base osteoarthritis (OA) is characterized by structural damage, most commonly evaluated by radiography. However radiography is insensitive. Magnetic resonance (MR) imaging could be…
Abstract Number: 1876 • 2017 ACR/ARHP Annual Meeting
A Non-Invasive Ultrasound Surface Wave Elastography Technique for Assessing Interstitial Lung Disease
Thomas Osborn¹, Xiaoming Zhang², Sanjay Kalra³, Boran Zhou⁴ and Brian Bartholmai⁵, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Mayo Clinic college of Medicine, Rochester, MN, ³Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁴Radiology, Mayo Clinic, Rochester, MN, ⁵Thoracic Radiology, Mayo Clinic, Rochester, MN
Background/Purpose: Surface wave elastography is an ultrasound based noninvasive technique to measure tissue viscoelasticity (“stiffness”). Preliminary studies in assessing scleroderma associated skin thickening have been…
Abstract Number: 1877 • 2017 ACR/ARHP Annual Meeting
The Performance of MRI Using the 3D Volumetric Interpolated Breath-Hold Sequence (VIBE) Technique to Detect Structural Changes in Patients with Early Axial Spondyloarthritis in Comparison to Conventional Radiography and Computed Tomography
Xenofon Baraliakos¹, Florian Hoffmann¹, Xiaohu Deng², Yanyan Wang³, Feng Huang⁴ and Jürgen Braun⁵, ¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Chinese PLA General Hospital, Chinese PLA General Hospital, Beijing, China, ³Rheumatology, Chinese PLA General Hospital, Beijing, China, ⁴Chinese PLA General Hospital, Beijing, China, ⁵Institut für angewandte Statistik Dr. Jörg Schnitker GmbH, Bielefeld, Germany
Background/Purpose: Magnetic resonance imaging (MRI) is the gold standard for detection of inflammation in the sacroiliac joints (SIJ) of patients (pts) with axial spondyloarthritis (axSpA),…
Abstract Number: 1878 • 2017 ACR/ARHP Annual Meeting
The Utility of the Omeract Ultrasound Tenosynovitis Scoring System in Multicenter Clinical Trials
Mads Ammitzbøll-Danielsen¹, Mikkel Østergaard¹, Esperanza Naredo², Annamaria Iagnocco³, Ingrid Moller⁴, Maria Antonietta D'Agostino⁵, Frédérique Gandjbakhch⁶ and Lene Terslev⁷, ¹Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ²Rheumatology, Joint and Bone Research Unit, IIS-FJD, Hospital Universitario Fundación Jiménez Díaz., Madrid, Spain, ³Academic Rheumatology Unit, Università degli Studi di Torino, Torino, Italy, ⁴Rheumatology, Instituto Poal, Barcelona, Spain, ⁵Department of Rheumatology, Assistance publique-Hôpitaux de Paris Ambroise Paré Hospital, Boulogne-Billancourt , Université Versailles Saint Quentin en Yvelines, Paris, France, ⁶Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, ⁷Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark
Background/Purpose :Tenosynovitis is very common in patients with RA and is associated with lower physical function. Several studies have confirmed the limitations of clinical examination…
Abstract Number: 1879 • 2017 ACR/ARHP Annual Meeting
Majority of Rheumatoid Arthritis Patients in Clinical Remission As Defined By DAS-28, CDAI, SDAI and RAPID-3 Have No Signal on Ultrasound Power Doppler
Allen P. Anandarajah¹, Andreea Coca² and Ralf G. Thiele³, ¹Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, ²University of Rochester Medical Center, Rochester, NY, ³Medicine, University of Rochester Medical Center, Rochester, NY
Background/Purpose: Remission in rheumatoid arthritis (RA) is often assessed using the following indices: disease activity scores (DAS-28), clinical disease activity index (CDAI), Simplified Disease Activity…
Abstract Number: 1880 • 2017 ACR/ARHP Annual Meeting
Cancer Immunotherapy in Patients with Preexisting Rheumatologic Disease: The Mayo Clinic Experience
Michael Richter¹, Olga Pinkston², Lisa Kottschade³, Heidi Finnes³, Svetomir N. Markovic⁴ and Uma Thanarajasingam⁵, ¹Internal Medicine, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic Florida, Jacksonville, FL, ³Oncology, Mayo Clinic, Rochester, MN, ⁴Department of Medicine and Oncology, Mayo Clinic, Rochester, MN, ⁵Division of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Immune checkpoint inhibitors have revolutionized the treatment of advanced malignancies. By blocking T-cell inhibition these drugs result in immune targeting of tumor cells and…
Abstract Number: 1881 • 2017 ACR/ARHP Annual Meeting
The Utility of Autoimmune Serologies in Recurrent and Chronic Inflammatory Eye Disease
Alexander Wu¹, Sulaiman Mapara², William Messner³, Sunil Srivastava⁴, Careen Lowder⁴ and Rula A Hajj-Ali⁵, ¹Internal Medicine, Cleveland Clinic, Cleveland, OH, ²Hospital Medicine, Cleveland Clinic, Akron, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Cole Eye Institute, Cleveland Clinic, Cleveland, OH, ⁵Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH
Background/Purpose: Inflammatory eye diseases such as scleritis and uveitis are associated with systemic autoimmune disease (SAD) and can be the initial manifestation of a concurrent…
Abstract Number: 1882 • 2017 ACR/ARHP Annual Meeting
Thymus and Activation-Regulated Chemokine (TARC) As Biomarker for IgG4-Related Disease
Masataka Umeda^1,2, Tomoki Origuchi³, Shinya Kawashiri^1,4, Tomohiro Koga^1,5, Kunihiro Ichinose¹, Yushiro Endo¹, Sousuke Tsuji¹, Ayuko Takatani¹, Takashi Igawa¹, Toshimasa Shimizu¹, Shoichi Fukui^1,4, Remi Sumiyoshi¹, Ayako Nishino^1,6, Naoki Iwamoto¹, Mami Tamai¹, Hideki Nakamura¹ and Atsushi Kawakami¹, ¹Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ²Medical Education Development Center, Nagasaki University Hospital, Nagasaki, Japan, ³Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan, ⁴Departments of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁵Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Japan, ⁶Center for Comprehensive Community Care Education, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Background/Purpose: TARC, also known as chemokine ligand 17 (CCR17), is expressed in the thymus and is produced by dendritic cells, endothelial cells, keratinocytes and fibroblasts.…
Abstract Number: 1883 • 2017 ACR/ARHP Annual Meeting
Patterns of Osteoarticular Involvement in SAPHO Syndrome: A Cluster Analysis Based on Whole Body Bone Scintigraphy in 157 Patients
Yihan Cao¹, Chen Li², Ping Xu¹, Yueting Li¹, Qiao Yang¹ and Xiaochuan Sun¹, ¹Peking Union Medical College, Beijing, China, ²Peking Union Medical College Hospital, Beijing, China
Background/Purpose: The aim was to explore patterns of osteoarticular involvement in SAPHO syndrome using cluster analysis of lesions revealed by whole body bone scintigraphy. Methods:…
Abstract Number: 1884 • 2017 ACR/ARHP Annual Meeting
Mepolizumab for the Treatment of Patients with Eosinophilic Granulomatosis with Polyangiitis: Post-Hoc Results of a Phase III Randomized, Placebo-Controlled Trial
Jonathan Steinfeld¹, Eric S Bradford², Judith Brown³, Stephen Mallett⁴, Steven W Yancey² and Michael E Wechsler⁵, ¹Respiratory TAU & Flexible Discovery Unit, GSK, Philadelphia, PA, USA, Philadelphia, PA, ²Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA, Research Triangle Park, NC, ³Research and Development, Immuno-Inflammation TAU, GSK, Stockley Park West, Uxbridge, Middlesex, UK, Uxbridge, United Kingdom, ⁴Research & Development, Statistics, GSK, Stockley Park West, Uxbridge, Middlesex, UK, Uxbridge, United Kingdom, ⁵Department of Medicine,, National Jewish Health, Denver, CO
Background/Purpose: In a recent Phase III study (NCT02020889) in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) the anti-interleukin-5 monoclonal antibody mepolizumab showed significant benefit when…
Abstract Number: 1885 • 2017 ACR/ARHP Annual Meeting
Epidemiology of Hospitalized Adult Onset Still’s Disease in United States
Bella Y. Mehta¹, William Briggs² and Petros Efthimiou³, ¹Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY, ²New York Presbyterian/ Brooklyn Methodist Hospital, New York, NY, ³Medicine/Rheumatology, New York University School of Medicine/NYU Langone Health, New York, NY
Background/Purpose: There is a dearth of epidemiological studies on Adult Onset Still’s Disease (AOSD) and no consensus on its incidence and prevalence. Most studies report…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].